214 related articles for article (PubMed ID: 18303938)
1. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
2. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
Curran MP
Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
[TBL] [Abstract][Full Text] [Related]
3. A single-pill combination of amlodipine besylate and atorvastatin calcium.
Blank R
Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
[TBL] [Abstract][Full Text] [Related]
4. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.
Devabhaktuni M; Bangalore S
Vasc Health Risk Manag; 2009; 5(1):377-87. PubMed ID: 19475775
[TBL] [Abstract][Full Text] [Related]
5. Amlodipine + atorvastatin single pill is the most effective choice for primary prevention.
Aalbers J
Cardiovasc J Afr; 2010; 21(4):243. PubMed ID: 20838732
[No Abstract] [Full Text] [Related]
6. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
Cowie MR
Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
[TBL] [Abstract][Full Text] [Related]
7. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
Ivanovic B; Tadic M
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
[TBL] [Abstract][Full Text] [Related]
9. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
10. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
Blank R; Hobbs FD; Zamorano J; Girerd X
Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
[TBL] [Abstract][Full Text] [Related]
11. Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.
Lin CP; Hsu TJ; Tung YC; Hsiao FC; Chou SH; Lin YS; Chen SW; Chu PH
J Am Heart Assoc; 2024 May; 13(9):e033780. PubMed ID: 38686894
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
Delgado-Montero A; Zamorano JL
Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
[TBL] [Abstract][Full Text] [Related]
13. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
Frishman WH; Zuckerman AL
Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
[TBL] [Abstract][Full Text] [Related]
15. EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA.
Naydenov Naydenov S; Margaritov Runev N; Ivanov Manov E; Georgieva Torbova-Gigova S
Acta Clin Croat; 2018 Sep; 57(3):464-472. PubMed ID: 31168179
[TBL] [Abstract][Full Text] [Related]
16. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
Grimm R; Malik M; Yunis C; Sutradhar S; Kursun A;
Vasc Health Risk Manag; 2010 May; 6():261-71. PubMed ID: 20479948
[TBL] [Abstract][Full Text] [Related]
18. The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study.
Neutel JM; Bestermann WH; Dyess EM; Graff A; Kursun A; Sutradhar S; Yunis C
J Clin Hypertens (Greenwich); 2009 Jan; 11(1):22-30. PubMed ID: 19125855
[TBL] [Abstract][Full Text] [Related]
19. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
[TBL] [Abstract][Full Text] [Related]
20. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
